title: Highlights in the treatment of chronic lymphocytic leukemia from the 2013 meeting of the American Society of Hematology.
abstract: The American Society of Hematology Annual Meeting includes physicians, scientists, administrators, medical students, graduate students, allied health professionals and exhibitors. This year’s meeting was held in New Orleans, LA. Presentations included a wide variety of topics in benign and malignant hematology. This year new data in the treatment of chronic lymphocytic leukemia, with particular focus on high unmet need populations, such as patients ‘unfit’ for intensive chemo-immunotherapy have been presented.
authors.affiliation: Department Hematology-Oncology, Azienda Ospedaliera Pugliese-ciaccio, Viale Pio X - 88100 Catanzaro, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Molica
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D006801:Humans; D007167:Immunotherapy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000401:mortality / Q000628:therapy*; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine